Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
20%
Ph not_applicable
4
80%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution5 total trials
Phase 3Large-scale testing
1(20.0%)
N/ANon-phased studies
4(80.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (20.0%)
N/A4 (80.0%)

Trials by Status

completed480%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruitingnot_applicable

Chinese American Cancer Survivors Writing Study

NCT05456100
completednot_applicable

Expressive Helping for Chinese-Speaking Cancer Patients and Survivors

NCT03945734
completednot_applicable

Bereaved Young Adults Study

NCT05352243
completedphase_3

Expressive Helping for Stem Cell Transplant Patients

NCT03800758
completednot_applicable

Chinese American Family Caregiver Writing Study

NCT05087576

Clinical Trials (5)

Showing 5 of 5 trials
NCT05456100Not Applicable

Chinese American Cancer Survivors Writing Study

Recruiting
NCT03945734Not Applicable

Expressive Helping for Chinese-Speaking Cancer Patients and Survivors

Completed
NCT05352243Not Applicable

Bereaved Young Adults Study

Completed
NCT03800758Phase 3

Expressive Helping for Stem Cell Transplant Patients

Completed
NCT05087576Not Applicable

Chinese American Family Caregiver Writing Study

Completed

All 5 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
5